Shanghai OPM Biosciences Co., Ltd.

688293

CNE100005PF1

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
37.81 ^CNY	+2.77%		+13.37%	-31.47%

Apr. 29	Shanghai OPM Biosciences Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 02	Tranche Update on Shanghai OPM Biosciences Co., Ltd.'s Equity Buyback Plan announced on October 31, 2023.	CI

Shanghai OPM Biosciences Co., Ltd.(SHSE:688293) added to Shanghai Stock Exchange Composite Index

September 05, 2023 at 12:00 am EDT

Shanghai OPM Biosciences Co., Ltd Added to Shanghai Stock Exchange Composite Index.

Latest news about Shanghai OPM Biosciences Co., Ltd.

Shanghai OPM Biosciences Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 28	CI
Tranche Update on Shanghai OPM Biosciences Co., Ltd.'s Equity Buyback Plan announced on October 31, 2023.	Apr. 01	CI
Shanghai OPM Biosciences Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 27	CI
Tranche Update on Shanghai OPM Biosciences Co., Ltd.'s Equity Buyback Plan announced on October 31, 2023.	Jan. 03	CI
Shanghai OPM Biosciences Co., Ltd. announces an Equity Buyback for CNY 100 million worth of its shares.	23-10-30	CI
Shanghai OPM Biosciences Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Shanghai OPM Biosciences Co., Ltd. authorizes a Buyback Plan.	23-10-27	CI
Shanghai Opm Biosciences Chairman Raises Stake	23-09-15	MT
Shanghai OPM Biosciences Co., Ltd.(SHSE:688293) added to Shanghai Stock Exchange Composite Index	23-09-05	CI
Shanghai OPM Biosciences Co., Ltd.(SHSE:688293) added to Shanghai Stock Exchange A Share Index	23-09-04	CI
Shanghai OPM Biosciences Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
Certain A Shares of Shanghai OPM Biosciences Co., Ltd. are subject to a Lock-Up Agreement Ending on 25-AUG-2023.	23-08-24	CI
Shanghai OPM Biosciences Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
Shanghai OPM Biosciences Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-23	CI
Shanghai OPM Biosciences Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-26	CI
Shanghai OPM Bioengineering Co., Ltd. announced that it expects to receive CNY 321.43 million in funding from Shanghai OPM Biosciences Co., Ltd.	22-09-22	CI
Shanghai OPM Biosciences Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-15	CI

Chart Shanghai OPM Biosciences Co., Ltd.

Duration

Period

Chart Shanghai OPM Biosciences Co., Ltd.

More charts

Shanghai Aopu Biotechnology Co Ltd is a China-based company mainly provides cell culture medium products and services. The Company's cell culture medium products are widely used in the manufacturing of protein, antibiotics, vaccine, cell therapy products, gene therapy products, and other biological products. The Company's contract development and manufacturing organization (CDMO) service platform provides comprehensive services covering antibody engineering humanized screening, cell strain cultivation, process development, pilot scale production, and clinical-stage sample production. The Company conducts businesses both in the domestic market and overseas markets.

Sector

Pharmaceuticals

Calendar

2024-08-20 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

37.81 CNY

Average target price

58.66 CNY

Spread / Average Target

+55.14%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Biopharmaceuticals

	1st Jan change	Capi.
SHANGHAI OPM BIOSCIENCES CO., LTD.	-31.47%	600M
SAMSUNG BIOLOGICS CO.,LTD.	+1.45%	40.51B
BIOGEN INC.	-15.94%	31.67B
UCB	+52.66%	24.62B
BIOMARIN PHARMACEUTICAL INC.	-14.50%	15.65B
INCYTE CORPORATION	-14.38%	12.07B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9.12%	11.97B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-42.56%	11.61B
SWEDISH ORPHAN BIOVITRUM AB	+4.87%	8.81B
INNOVENT BIOLOGICS, INC.	-4.33%	8.5B

Biopharmaceuticals